Autonomic dysfunction in parkinsonian LRRK2 mutation carriers

Parkinsonism Relat Disord. 2013 Oct;19(10):906-9. doi: 10.1016/j.parkreldis.2013.05.008. Epub 2013 Jun 10.

Abstract

Introduction: The aim of this study was to compare autonomic function in PD symptomatic carriers of the LRRK2 mutations and idiopathic Parkinson's disease (iPD) patients.

Material and methods: We studied 25 PD patients: 12 with the LRRK2 mutation (6 G2019S and 6 R1441G), and 13 with iPD. All patients underwent blood pressure and heart rate monitoring during head up tilt, Valsalva maneuver and deep breathing, along with recording of sympathetic skin response (SSR) and cardiac MIBG scintigraphy.

Results: Three of the patients with iPD and one of the LRRK2 carriers had orthostatic hypotension. Arterial pressure "overshoot" during phase IV of Valsalva maneuver was less pronounced in patients with iPD. During passive tilt, LRRK2 carries had higher increase of blood pressure than iPD patients MIBG late myocardial/mediastinal uptake ratios were higher in LRRK2 mutation carriers (1.51 ± 0.28 vs 1.32 ± 0.25; p < 0.05).

Discussion: Carriers of the LRRK2 mutation had less autonomic impairment than those with iPD as shown by higher cardiac MIBG uptake and a tendency to less impairment of autonomic non-invasive tests. It is important to carry out larger studies comparing the clinical, functional and pathological characteristics of these patients.

Keywords: Autonomic disorders; LRRK2 gene; Parkinson's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Iodobenzylguanidine
  • Aged
  • Autonomic Nervous System Diseases / diagnostic imaging
  • Autonomic Nervous System Diseases / etiology*
  • Autonomic Nervous System Diseases / genetics*
  • Blood Pressure / physiology
  • Female
  • Heart / diagnostic imaging
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Mutation / physiology*
  • Norepinephrine / blood
  • Parkinson Disease / complications*
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / genetics*
  • Positron-Emission Tomography
  • Protein Serine-Threonine Kinases / genetics*
  • Radiopharmaceuticals
  • Skin / innervation
  • Surveys and Questionnaires
  • Sympathectomy
  • Valsalva Maneuver

Substances

  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases
  • Norepinephrine